Background--Clinical studies suggest that hypercholesterolemia may cause ageing in hematopoietic stem cells (HSCs) because ageing-associated alterations were found in peripheral blood cells and their bone marrow residing precursors in patients with advanced atherosclerosis. We hypothesized that hypercholesterolemia induces oxidant stress in hematopoietic stems cells that accelerates their ageing.
H
ypercholesterolemia is recognized as a major risk factor for cardiovascular disease and increases all-cause mortality in different epidemiological studies. [1] [2] [3] Little is known about the detrimental effects of hypercholesterolemia on hematopoietic stem cells (HSCs). Clinical investigations and basic research have implied that hypercholesterolemia acclerates ageing of HSCs. The first evidence was the finding of shorter telomeres in peripheral blood leukocytes of human patients with advanced atherosclerosis. 4 Spyridopoulos et al
showed that the telomere length of peripheral white blood cells in patients with atherosclerotic disease correlates with the telomere lengths of their bone marrow-residing hematopoietic precursors. 5 Shortening of telomeres is recognized as one of the major ageing-associated alterations responsible for the loss of regenerative potential in tissues, 6 and is also linked to the initiation and/or progression of cardiovascular disease. 7 The other evidence indicated that hypercholesterolemia skewed myeloid lineage differentiation in human patients, which has been closely related to ageing of HSCs. 8, 9 Hypercholesterolemic mice deficient in ABCA1 and ABCG1 displayed a dramatic expansion of HSC compartment and in the bone marrow. 10 ApoE-deficient mice fed a western diet developed the same prominent expansion of the HSC compartment in the bone marrow. 11 These mouse models also displayed myeloproliferative disorder. These abnormal alterations in HSCs suggest that hypercholesterolemia may cause ageing of HSCs, but the mechanism by which hypercholesterolemia causes these effects remains unknown.
In the present study, we found that hypercholesterolemia induces oxidant stress in HSCs that alters their gene expression and cell cycle regulation. Together these effects lead to ageing of HSCs manifested by telomere erosion, loss of quiescence, reduction in long-term HSC compartment, and impaired reconstitution capacity of HSCs.
Preparation of Lentiviral Particles
The pLenti expression plasmids were purchased from Open Biosystems. Second generation packing system was purchased from Applied Biosystems. Lentiviral particles were produced by transient transfection with 293T cells as indicated by manufacture protocol.
In Vitro Culture of HSCs
KTLS cells were cultured in Minimum Essential Media alpha modification (aMEM Sigma) containing 12.5% FCS (JRH Bioscience), 12.5% horse serum (Gibco BRL) and 1 nmol/L dexamethasone. For some experiments, we added 10 lmol/L SB203580 or 5 lmol/L c secretase inhibitor XII (Calbiochem) into culture medium.
Immunocytochemistry
We used a standard cytocentrifuge protocol to detect nitrotyrosine and oxLDL in HSCs. The antibody against oxidized phospholipids with a phosphopcholine headgroup was a gift from J. Witztum (University of California San Diego). The antibody against nitrotyrosine was purchased from Cell Signaling Technology. We used rabbit-specific IgG conjugated with FITC (Invitrogen) as a secondary antibody. For nuclear staining, we treated specimens with DAPI (Molecular Probes). Fluorescent images were obtained using a confocal laserscanning microscope (Carl Zeiss LSM 510 system; Carl Zeiss).
Competitive Bone Marrow Reconstitution Assay
We sorted KTLS cells from wild-type or ApoE À/À mice (CD45.2).
We transplanted cells into lethally irradiated CD45.1 congenic mice in competition with HSCs from CD45.1 mice. We monitored reconstitution of donor (CD45.2) myeloid and lymphoid cells by staining blood cells with antibodies against CD45.2, CD45.1, CD3, B220, Mac-1, and Gr-1.
Sample Generation and DNA Microarray Hybridization and Analysis
KTLS cells were isolated as described. For the purpose of this assay only, KTLS cells pooled from 4 to 5 mice were used to generate a single KTLS sample. Total RNA was isolated using RNeasy Micro kit according to manufacturer's instructions (Qiagen). Total RNA was amplified in 2 rounds using the Amino Allyl MessageAmpII kit (Ambion). Five micrograms of amplified RNA, quantified using a NanoDrop ND-100 spectrophotometer (NanoDrop Technologies), was dried and then coupled to a fluorescent dye (Cy3 or Cy5). Equal amounts of Cy3 or Cy5 labeled aRNA (825 ng) obtained from 2 different samples (ApoE À/À or WT) were hybridized to Agilent Mouse Whole Genome Microarrays 4944K for 17 hours at 65°C. The hybridized microarrays were washed and scanned using an Agilent G250B scanner. Four microarrays were carried out on RNA samples from discrete groups of ApoE À/À and WT mice, including one dye swap array. Data were extracted from the scanned image for preprocessing and normalization with Feature Extraction Software (v 9.5.3.1; Agilent Technologies, Inc). Data used for further analysis came from green and red Processed Signal values, generated after background subtraction and LOWESS normalization. Fold change was calculated as the ratio of red to green signal intensity. A list of candidate genes was identified, which demonstrated an average >2-fold increase or decrease in expression. The list was created from a filtered set of the data that included genes that were >1.5-fold changed in the same direction, in 4/4 microarrays. Data were further processed using GeneSpring GX software (Agilent Technologies, Inc) and Ingenuity Pathway Analysis (Ingenuity â Systems, www.ingenuity.com).
excitation wavelength for oxidized DCF was 488 nm, and emission was 525 nm. 
RT-PCR and qRT-PCR Array
RNA was isolated from cells using RNAqueous-Micro kit (Ambion Life Technologies). Transcription to cDNA was performed using SuperScript III (Invitrogen). The primers were purchased from Operon. The expression of ROS genes was detected by Mouse Oxidant Stress and Antioxidant Defense PCR Array (SABiosciences). All PCRs were carried out in triplicate using an Eppendorf Mastercycler (Eppendorf). Primer sequences are shown in Table 1 .
Telomere Length Measurement
Telomere length was measured by telomere PNA kit/FITC (DAKO). In brief, the sample DNA was denatured for 10 minutes at 82°C in a microcentrifuge tube either in the presence of hybridization solution without probe or in hybridization solution containing fluorescein-conjugated PNA telomere probe. Then hybridization took place in the dark at room temperature (RT) overnight. The hybridization was followed by two 10-minute post-hybridization washes with a Wash Solution at 40°C. The sample was then resuspended in an appropriate buffer for further flow cytometric analysis. DNA Staining Solution included in the kit was used for identification of G0/1 cells. After flow cytometric analysis, the data obtained were used for determination of a relative telomere length (RTL). The RTL value was calculated as the ratio between the telomere signal of each sample and the control cell (1301 cell line) with correction for the DNA index of G0/1 cells.
Statistical Analysis
All data were shown as meansAESD. Figure 1C ). As well, the proportion of the highly purified side population of total KTLS cells in ApoE À/À mice was significantly lower than that in WT mice ( Figure 1D ). (Figure 2A ), while the ratio of phenotypically defined LT-HSCs in total KTLS population significantly decreased ( Figure 2B ).
Telomere length was also significantly shorter than KTLS cells from WT mice on normal chow diet ( Figure 2C ). Side population of KTLS was 3-fold fewer than those in WT mice on normal chow diet ( Figure 2D ). A similar impairment of reconstitution capacity occurred after transplantation of KTLS cells from HCD mice ( Figure 2E ). The findings derived from high-cholesterol-diet-fed mice excluded the possibility that the deleterious effects of hypercholesterolemia on HSCs were due to loss of Apolipoprotein E expression. Taken together, these results indicate that hypercholesterolemia accelerates the ageing of HSCs manifested by loss of quiescence, expansion of the HSC compartment, and a decrease in their reconstitution capacity. 
ROS Levels are Greater in HSCs From Hypercholesterolemic Mice
Oxidant stress has been suggested as a major factor that causes ageing and senescence of HSCs.
12,13 Therefore, we determined whether hypercholesterolemia induces oxidant stress in HSCs. Significantly higher reactive oxygen species (ROS) levels were shown in KTLS cells from ApoE À/À mice than WT mice by DCF staining ( Figure 3A ) and H 2 O 2 assay ( Figure 3B ). DCF staining and flowcytometry showed that ROS levels in total bone marrow cells had no significant difference between WT, HCD mice and ApoE À/À mice ( Figure 3C ).
Treatment of ApoE
À/À mice with the antioxidant N-acetylcysteine (NAC) or GSH significantly reduced ROS levels within their KTLS cells ( Figures 3A and 3B ).
To gain insight into the basis for oxidant stress in HSCs from hypercholesterolemic mice, we profiled the expression of genes involved in antioxidant defense and ROS metabolism by RT-PCR ( Table 2 ). The expression of antioxidant genes, including Duox1, Sod1, Srxn1, and Prdx6-ps1 was paradoxically significantly lower in ApoE À/À KTLS cells ( Figure 3D ; Table 3 ). In addition, Nox1, which is involved in reactive oxygen species metabolism, was significantly downregulated in ApoE À/À KTLS cells.
Treatment with NAC or GSH reversed the oxidant-induced changes in the KTLS cells of ApoE
À/À mice. KTLS frequency in the bone marrow of NAC-or GSH-treated ApoE À/À mice decreased to 0.07AE0.01 or 0.08AE0.01 respectively ( Figure 3E ). The mean relative telomere length of KTLS cells from NAC-or GSH-treated ApoE À/À mice increased by 18% or 14% respectively ( Figure 3F ). Finally, NAC and GSH significantly restored the reconstitution capacity of ApoE À/À KTLS cells to a level comparable to that in WT KTLS cells ( Figure 3G ). Consistent with the findings in ApoE À/À mice, KTLS cells from HCD mice also showed significantly greater ROS levels ( Figure 4A ) and nitrotyrosine accumulation than KTLS cells from WT mice ( Figures 4B and 4C ). These findings indicate that hypercholesterolemia induces oxidant stress in HSCs that causes accelerated ageing manifested by loss of quiescence, expansion of the HSC compartment, and impaired reconstitution capacity. Oxidized low-density lipoprotein (oxLDL) accumulates and causes oxidant stress in a variety of cells and tissues. Oxidized-LDL has also been found in the peripheral blood cells of mouse models of hypercholesterolemia.
14 In our study, KTLS cells from ApoE À/À mice showed accumulation of oxLDL but none was found in those from WT mice ( Figure 5A ). We screened for the expression of major oxLDL receptors, including scavenger receptors A1/A2 (SRA1, A2), scavenger receptors B1/B2 (SRB1, B2), CD36, CD68, and lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) in KTLS from WT and ApoE À/À mice. SRB2 and LOX-1 were detected 5G ). To verify the role of SRB2 and LOX-1 in the uptake of oxLDL, we inhibited the expression of SRB2 and LOX-1 by Lentivirus mediated shRNA against SRB2 or LOX-1 ( Figures 5H and 5I ). The inhibition of SRB2 or LOX-1 both significantly decreased the uptake of oxLDL by KTLS cells in vitro, while simultaneous inhibition of SRB2 and LOX-1 caused a synergystic decrease in the uptake of oxLDL ( Figure 5J ). These findings indicated that HSCs take up oxLDL by a receptor-mediated mechanism. Exposure of WT KTLS cells to oxLDL in vitro significantly increased oxidant stress (Figure 6A ), decreased phenotypically defined LT-HSC population ( Figure 6B ), and reduced their reconstitution capacity in a concentration-dependent manner ( Figure 6C ). All these findings indicate that intracellular accumulation of oxLDL causes oxidant stress and accelerates ageing in HSCs of hypercholesterolemic mice.
In the previous studies, other mouse models of hypercholesterolemia have been used to investigate the effects of hypercholesterolemia onto HSCs, including ABCA1
À/À or ApoE À/À mice fed on high-fat diet (HFD). 10, 11 To further address the deleterious effects of hypercholesterolemia on HSCs, we reproduced the conditions of these studies by feeding ApoE À/À mice the same HFD used in these studies. The frequency of KTLS cells in these mice was 0.2% of total bone marrow cells, significantly higher than that in ApoE À/À mice on normal chow ( Figure 7A ). Consistent with this further expansion of KTLS compartment of Apo E À/À fed by HFD, DCF staining showed higher oxidant accumulation in KTLS cells as well ( Figure 7B ). More importantly, the HFD also induced a very significant monocytosis ( Figures 8A through  8D ) and >2-fold increase of spleen size ( Figure 8E ). Additionally, we measured serum cholesterol levels in ApoE À/À mice fed this specific HFD. The total serum cholesterol levels were exceedingly high, close to 1000 mg/dL ( Figure 8F ) which is comparable to the reported in the previous studies. showed that phosphorylation of p38 MAPK was greater in KTLS cells from ApoE À/À mice, while the expression of total p38 showed no difference ( Figure 9A ). Figure 9D ). FACS analysis also showed greater phosphorylation of p38 MAPK in KTLS from HCD mice ( Figure 9E ). Treatment with p38 inhibitor SB203580 significantly increased the proportion of phenotypically defined LTHSCs in ApoE À/À mice, but had no effect on the proportion of phenotypically defined LT-HSCs from WT mice ( Figures 9F  and 9G ). Moreover, inhibition of p38 improved the reconstitution capacity of KTLS cells from ApoE À/À mice; whereas MEK1 inhibitor PD98059 had no effect on reconstitution capacity ( Figure 9H ). The findings suggested that the effect of hypercholesterolemia-induced oxidant stress on HSC ageing is mediated via activation of p38 MAPK.
To identify the molecular mechanisms that underlie the accelerated ageing of HSCs from hypercholesterolemic mice, we screened HSC genomic expression by microarrays which showed that of the genes that were differentially expressed, 398 genes were upregulated and 173 were downregulated Control 0μg/ml nLDL 10μg/ml nLDL 20μg/ml nLDL 0.1μg/ml oxLDL 1μg/ml oxLDL 10μg/ml oxLDL 20μg/ml oxLDL level was measured by DCF staining in WT KTLS cells treated with 0 lg/mL nLDL (7.5AE0.9%), 10 lg/mL nLDL (8.7AE1.2%), 20 lg/mL nLDL (11.6AE1.7%), 0.1 lg/mL oxLDL (9.8AE0.6%), 1 lg/mL oxLDL (11.7AE1.6%), 10 lg/mL oxLDL (28.5AE.4% *) and 20 lg/mL oxLDL (39.8AE5.7% **). The numbers represent MAESD (n=8, *P<0.05, **P<0.01 vs 0 lg/mL nLDL group). B, Phenotypically defined LT-HSC population of WT KTLS cells in vitro culture was measured by Flowcytometry. The number of LT-HSC was represented as percent of total KTLS cells (MAESD, n=8, *P<0.05, **P<0.01, vs control). C, Competitive HSC transplantation assay of WT KTLS cells treated with oxLDL. The percent of CD45.2 + cells in peripheral blood were represented as MAESD (n=8, *P<0.05, **P<0.01, vs control). LT-HSC indicates long-term hematopoietic stem cell; oxLDL, oxidized lowdensity lipoprotein; ROS, reactive oxygen species; WT, wild type.
( Figure 10A ). These candidate genes were further evaluated by Ingenuity Pathways Analysis. Four significant canonical pathways were identified: p53 signaling; G 2 /M DNA damage checkpoint regulation; IL-8 signaling; and one carbon pool by folate ( Figure 10B ). These pathways all involve cell cycle regulation. The Cip/Kip family of CDK inhibitors was consistently represented in each pathway. Ingenuity Pathways Analysis indicated high Notch1 activity in KTLS cells from ApoE À/À mice ( Figure 10C ).
Besides the Cip/Kip family, the Ink4 family also responds to increased ROS and regulates HSC function. 11 Expression of p19 Arf , p21 Waf1 , and p27 Kip1 were significantly increased in KTLS cells from ApoE À/À mice, which was reversed by NAC or SB203580 treatment, but not by treatment with PD98059 ( Figure 11A ). The expressions of p19 Arf , p21
Waf1
, and p27
Kip1
were higher in phenotypically defined LT-HSCs than in ST-HSCs from ApoE À/À mice ( Figure 11B ). 
Notch1 Expression is Greater in HSCs From Hypercholesterolemic Mice
Ingenuity Pathway Analysis also suggested that Notch signaling might be increased in HSCs isolated from hypercholesterolemic mice ( Figure 10C ). RT-PCR confirmed that the expression of Notch1 was greater in HSCs from hypercholesterolemic mice ( Figure 13A ). Further, Notch1 expression was significantly greater in phenotypically defined ST-HSCs than LT-HSCs in WT and ApoE À/À mice; however, Notch1 expression in ApoE À/À ST-HSCs was significantly greater than that in WT ST-HSC ( Figure 13B ). Treatment of hypercholesterolemic mice with antioxidant NAC or p38 inhibitor SB203580 significantly reduced the expression of Notch1 in HSC from ApoE À/À mice ( Figures 13A and 13C ).
The treatment of WT KTLS cells in vitro with SB203580 also decreased Notch1 expression in a concentration-dependent manner ( Figure 13D ). The inhibition of p38 also upregulated the expression of Sirt1, which has been shown to reduce Notch activity by cleaving Notch intracellular domain. MG132, an inhibitor of Sirt1, reversed the decrease of the Notch intracellular domain caused by SB203580 treatment ( Figure 13E ). These findings indicate that the ROS-p38 axis augments Notch1 activity in HSCs of hypercholesterolemic mice. Treatment of hypercholesterolemic mice in vivo with the c-secretase inhibitor, DAPT, significantly decreased the size of KTLS compartment and increased the number of phenotypically defined LT-HSCs, while in vitro treatment of KTLS cells with DAPT significantly decreased proliferation ( Figures 13F  and 13G ). The findings are supported by a previous study. 15 Together, these results indicate that the ROS-p38-induced increase of Notch1 activity drives the expansion of HSC compartment in hypercholesterolemic mice. limited number enter the cell cycle, which is driven by both extrinsic and intrinsic cues. Recent studies showed that increased oxidant stress exerts a critical role in the regulation of HSC quiescence and function. 13, 16 In the present study, we found that HSCs isolated from two different mouse models of hypercholesterolemia possessed abnormal accumulation of ROS, while ROS levels in total bone marrow cells were similar in hypercholesterolemic mice and WT mice, indicating that hypercholesterolemia induces oxidant stress specifically in HSCs. PCR array analysis confirmed an aberrant expression of a subset of ROS genes in HSCs isolated from hypercholesterolemic mice. The long-term treatment with antioxidants, NAC and GSH, effectively decreased oxidant stress, and restored the quiescence as well as the reconstitution capacity of HSCs from hypercholesterolemic mice. This effect was present in a well-established mouse model of hypercholesterolemia (ApoE À/À ), as well in C57Bl/6 mice in whom hypercholesterolemia was diet-induced; thus, it is clear that hypercholesterolemia causes oxidant stress and impairs the quiescence and function of HSCs. The importance of the present findings is that it extends the known deleterious effects of hypercholesterolemia to HSCs, a common clinical entity and one that has clear impact on morbidity and mortality. [1] [2] [3] A previous study showed that antioxidant GSH reversed IL-3 induced abnormal myelopoiesis of total bone marrow cells isolated from hypercholesterolemic ABCA1
mice, but it failed to reverse the abnormal myelopoiesis with antioxidant NAC. 10 However, in that study, total bone marrow cells rather than HSCs were studied. In addition, myelopoiesis of total bone marrow mononuclear cells was measured 72 hours after their harvest in an in vitro assay. In this study, oxidant stress was measured in HSCs. These differences in techniques and experimental design could account for the different observations between this study and the other published studies. Based on the exaggerated monocytosis, spleen size, and serum cholesterol level found in HFD fed ApoE À/À mice, we hypothesized that HFD mice caused marked systemic inflammation in ApoE À/À mice that resulted in extramedullary hematopoiesis and monocytosis. A very recent study supports this explanation of the findings. 17 The study indicated that HFD caused a similar, very significant monocytosis and accelerated atherosclerosis in ApoE À/À mice in response to inflammation.
Furthermore, this phenotype was largely attributed to extramedullary hematopoiesis in spleen, rather than the changes of HSCs in the bone marrow. Obviously, the total serum cholesterol levels of almost 1,000 mg/dl in HCD fed ApoE À/ À mice are extraordinarily high and have much less clinical relevance than do the levels in our study, %240 mg/dL. These findings suggest caution while investigating the effects of hypercholesterolemia on hematopoiesis or HSCs in ApoE À/À mice fed a HFD, due to these extraordinarily high serum cholesterol levels and attendant systemic inflammation. These previous studies also showed that hypercholesterolemic ABCA1-and ABCG1-deficient mice as well as ApoE mice fed a western diet displayed a dramatic expansion of HSCs in the bone marrow. 10, 11 These studies suggest that the abnormal expansion of the HSC compartment was related to an increased membrane cholesterol content that induces increased cell-surface IL-3 or GM-CSF receptors and thereby increases the HSC proliferative response to IL-3 and GM-CSF. However, these studies did not address the question if hypercholesterolemia accelerates ageing in hematopoietic progenitor/stem cells. In agreement with the clinical investigations, 4,10 our results showed hypercholesterolemiainduced oxidant stress that caused loss of quiescence in the HSC compartment, evidenced by increased proportion of phenotypically defined ST-HSCs within the bone marrow, reduced proportion of phenotypically defined LT-HSC and side population as well as telomere shortening and reduced reconstitution capacity of HSC population. Our findings indicate that hypercholesterolemia accelerates ageing in HSCs in oxidant stress dependent manner, which cause the loss of quiescence of LT-HSC compartment, force more LT-HSCs into cell cycle, and result in telomere erosion and expansion of ST-HSC compartment with expense of impaired reconstitution capacity of HSCs in hypercholesterolemic mice. We have found that oxidant stress in bone marrow cells of hypercholesterolemic mice occurs in a cell type-specific manner. Interestingly, although HSCs express LOX-1, this expression was significantly lower in HSCs than in other bone marrow cells. It is well established that most HSCs are quiescent in the bone marrow. Therefore, the lower expression of LOX-1 in the HSC compartment may protect HSCs from accumulation of oxLDL and secondary oxidant stress. A previous study reported similar cell type specific changes that were consistent with the protection of HSCs from oxidant stress. In this study, ABCA1 and ABCG1 were expressed at much higher levels in HSCs than other bone marrow cells. 10 The cell type-specific differences in the sensitivity of bone marrow cells to oxidant stress may also be related to differences in the HSC microenvironment. For example, HSCs reside in a relatively hypoxic area of the bone marrow and therefore may not have robust antioxidant defense systems. In support of this hypothesis, we found HSCs of ApoE À/À mice displayed an unexpected pattern of downregulation of many antioxidant genes. To elucidate the mechanism underlying the effects of hypercholesterolemia on HSC quiescence and reconstitution capacity, we focused on the Cip/Kip and Ink4 cell cycle inhibitor families, which maintain the quiescence of HSCs, thereby governing their available pool size. [18] [19] [20] showed that p38 phosphorylation was significantly higher in the HSCs from hypercholesterolemic mice. The inhibition of p38 restored the quiescence and reconstitution capacity of HSCs in hypercholesterolemic mice. It has also been shown that the Cip/Kip and Ink4 families are regulated by MAPKs, including p38 and Erk. [25] [26] [27] In concordance with these results, the inhibition of p38 also rescued the aberrant expression of the Ink4 and Cip/Kip families in hypercholesterolemic mice. These results indicated that hypercholesterolemia-induced oxidant stress increased phosphorylation of p38 in HSCs from hypercholesterolemic mice was central to the loss of quiescence and repopulation capacity. We also found a significant increase in the expression of Notch1 in HSCs from hypercholesterolemic mice. Notch1 expression was decreased in HSCs after inhibition of p38 MAPK in vivo and in vitro. In addition, p38 inhibitor SB203580 upregulated the expression of Sirt1, which has been shown to negatively modulate Notch activity in HSCs. 28 These results reinforce that the p38 pathway also augments the activity of Notch1 under conditions of hypercholesterolemia-induced oxidant stress. It has been shown that exposure of HSCs to Notch ligand induces their self-renewal and expansion. 29 We found that treatment with DAPT significantly decreased the HSC compartment in vivo and the proliferation of HSCs from hypercholesterolemic mice in vitro. These results indicate that the p38-dependent increase in Notch1 activity contributes to expansion of the HSC compartment in hypercholesterolemic mice. Taken together, we provide evidence that hypercholesterolemia can cause oxidant stress that accelerates the ageing and impairs the reconstitution capacity of HSCs. The novel mechanism identified in the present study should lead to additional studies to determine if hypercholesterolemiainduced oxidant stress also impairs HSC differentiation and thereby affect immunity and inflammation. Such findings could lead to new insights into the mechanisms by which hypercholesterolemia increases all-cause mortality.
